Compare Viavi Solutions Inc. Common Stock (VIAV) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Viavi Solutions Inc. Common Stock vs State Street SPDR S&P Biotech ETF — how do they compare? Viavi Solutions Inc. Common Stock trades at $45.46 (market cap $10.85B), while State Street SPDR S&P Biotech ETF trades at $153.85 (market cap $10.11B). The key difference: Viavi Solutions Inc. Common Stock and State Street SPDR S&P Biotech ETF are close in size by market cap, and State Street SPDR S&P Biotech ETF is more actively traded (12,903,266 versus 4,281,289). Which is the better fit depends on your goals — on Pluang, investors hold Viavi Solutions Inc. Common Stock for 1 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| VIAV | XBI | |
|---|---|---|
Market Cap | $10.85B | $10.11B |
Volume | 4,281,289 | 12,903,266 |
Sector | Technology | Broad Market / Factor |
52-Week High | $55.33 | $169.55 |
52-Week Low | $12.27 | $104.99 |
Typical Hold Time | 1 Days | 38 Days |
Enterprise Value | $10.89B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.
Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Viavi Solutions Inc. Common Stock
Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
